October The hospital in Cincinnati and the girl's parents told ISDH she had been at a church gathering in northwestern Indiana on May 15 where a fellow attendee had been ill. This fellow attendee was an adolescent girl aged 17 years, an Indiana resident who had not been vaccinated for measles and who had worked during May 4-14 as a missionary in an orphanage and hospital in Bucharest, Romania, where a large measles outbreak was subsequently reported. The teen had returned to the United States with prodromal fever, cough, conjunctivitis, and coryza, traveling on international and domestic commercial airliners on May 14. The next day the teen attended the church gathering along with others who had not been vaccinated because of nonmedical exemptions. Family members recalled that the teen had a rash on May 16; measles was diagnosed retrospectively, and the teen was identified as the index patient. An outbreak investigation was conducted by ISDH and CDC. This report summarizes 1) the results of that investigation, which identified 34 persons with measles, including three who required hospitalization, 2) the measures taken to control and prevent measles transmission, and 3) recommendations to prevent future cases of measles.
Import-Associated Measles Outbreak -Indiana, May-June 2005
On May 29, 2005, the Indiana State Department of Health (ISDH) was notified of suspected measles in a female Indiana resident aged 6 years who was hospitalized in Cincinnati, Ohio, where she had been visiting relatives. Serologic analyses performed by the Ohio State Department of Health Laboratory and a private reference laboratory confirmed the diagnosis of measles. The hospital in Cincinnati and the girl's parents told ISDH she had been at a church gathering in northwestern Indiana on May 15 where a fellow attendee had been ill. This fellow attendee was an adolescent girl aged 17 years, an Indiana resident who had not been vaccinated for measles and who had worked during May 4-14 as a missionary in an orphanage and hospital in Bucharest, Romania, where a large measles outbreak was subsequently reported. The teen had returned to the United States with prodromal fever, cough, conjunctivitis, and coryza, traveling on international and domestic commercial airliners on May 14. The next day the teen attended the church gathering along with others who had not been vaccinated because of nonmedical exemptions. Family members recalled that the teen had a rash on May 16; measles was diagnosed retrospectively, and the teen was identified as the index patient. An outbreak investigation was conducted by ISDH and CDC. This report summarizes 1) the results of that investigation, which identified 34 persons with measles, including three who required hospitalization, 2) the measures taken to control and prevent measles transmission, and 3) recommendations to prevent future cases of measles.
Persons with measles were defined as having generalized maculopapular rash, fever of >101 º F (>38.3 º C), and at least one of the following: cough, coryza, or conjunctivitis. Measles cases were either laboratory-confirmed or met the clinical case definition and were linked epidemiologically to a patient with confirmed measles. Onset of rash for the 34 persons identified with measles occurred during May 16-June 24 (Figure) . Of the 34 cases, 33 (97%) were in church members who acquired disease either through direct exposure to the index patient or household exposure to a person with measles who had been exposed to the index patient. The remaining case was in a phlebotomist, with rash onset on June 24, who worked in an Indiana hospital where one of the measles patients had 
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June cination levels (4) . Of 540 measles cases in the United States during 1997-2001, 362 (67%) were linked to imports (i.e., 196 imported cases, 138 cases epidemiologically linked to imported cases, and 28 cases associated with an imported measles virus genotype), and most measles cases could have been prevented (5) . Because the disease is endemic or epidemic in many parts of the world (6) , the Advisory Committee on Immunization Practices (ACIP) recommends that all persons who travel internationally be vaccinated for measles to reduce the risk for infection among travelers (7) . ACIP further recommends that all preschool children in the United States receive 1 dose of MCV and all school-aged children receive 2 doses of MCV. Although all states require 2 doses of MCV for children attending school, nonmedical exemptions are permitted by certain states, including Indiana. Persons choosing a nonmedical exemption from vaccination are approximately 22 times more likely to acquire measles than persons who are vaccinated (8) . Parents and persons who opt out of vaccination should be aware of the risk that this practice places upon their children and their community. Communities of persons who have not been vaccinated can make intensive measles-containment activities necessary (9) .
ACIP also recommends that persons who work in medical facilities be vaccinated for measles (10) . The Indiana outbreak, in which a hospital worker contracted measles, demonstrates the need for health-care facilities to be aware of the vaccination status of their workers and require written documentation of vaccination history.
The Indiana outbreak could have been prevented by adherence to long-standing ACIP recommendations calling for measles vaccination of 1) international travelers, 2) children, and 3) health-care workers. The serious illnesses that resulted from this outbreak and the size and scope of activities and resources required to contain it underscore the need to adhere to these recommendations to sustain elimination of measles in the United States.
In 1986, an estimated 3.5 million cases of dracunculiasis occurred in 20 countries, and 120 million persons were at risk for the disease (1) . That year, the World Health Assembly adopted a resolution calling for the eradication of dracunculiasis, also known as Guinea worm disease (2) . This report describes the status of the global dracunculiasis eradication program as of July 2005 (3, 4) , indicating that, during JanuaryJuly 2005, a total of 8,191 indigenous cases of dracunculiasis were reported from nine countries, with at least 150 million persons at risk. Despite the substantial reductions in dracunculiasis cases since 1986, eradication of dracunculiasis will require international commitment and ongoing surveillance and intensified interventions at national, state, and local levels.
At the end of 2004, Asia was free from dracunculiasis. The remaining countries where dracunculiasis was endemic, all in Africa, had reported 50% reductions in the number of cases from 2003 to 2004 (from 32,193 to 16,026), and 11 (Benin, Cameroon, Central African Republic, Chad, India, Kenya, Mauritania, Pakistan, Senegal, Uganda, and Yemen) of the original 20 countries with endemic disease had interrupted Editorial Note: Dracunculiasis is a parasitic infection caused by Dracunculus medinensis. Persons become infected by drinking water from ponds contaminated by copepods (water fleas) that contain immature forms of the parasite. One year later, adult worms approximately 1 meter (40 inches) in length emerge through skin lesions, usually on the lower limbs, which frequently develop severe secondary bacterial infections. No effective treatment or vaccine for the disease exists, and infected persons do not become immune to future infections by the parasite. However, dracunculiasis can be prevented by 1) filtering drinking water through a finely woven cloth, 2) treating contaminated water with the larvicide ABATE ® (temephos) (BASF, Ludwigshafen, Germany), 3) providing clean water from borehole or hand-dug wells (5), and 4) educating persons to avoid entering water sources when Guinea worms are emerging from their bodies.
Momentum toward eradication of dracunculiasis is accelerating, with substantial reductions in cases in 2004 The reduction in cases exported from southern Sudan to the northern states and to neighboring countries indicates that the recent decline in cases in Sudan is real. The reductions in cases within southern Sudan are a net result of underreporting (e.g., poor surveillance in some areas with endemic disease), overreporting (e.g., poor surveillance resulting from failure to adhere to the case definition or reporting of fictitious cases), inaccessibility to disease-endemic areas with ongoing civil conflicts, access to newly secure areas, and the effects of interventions by Sudan's Guinea Worm Eradication Program. A challenge grant provided by the Bill & Melinda Gates Foundation in support of the dracunculiasis eradication program and the recent peace agreement should remove major obstacles to eradication in southern Sudan.
The increased rate of reduction of cases, the reduction in cases exported to other countries during [2004] [2005] , and the peace agreement in Sudan indicate that the final phase of the global dracunculiasis eradication program might be executed without further delays and be concluded by the target date of 2009 (6) . Recent development of a reliable means to distinguish D. medinensis from other species of Dracunculus (i.e., by sequence analysis of the 18S RNA) (7) will facilitate investigation of sporadic cases at this stage by eliminating false positives in areas now free from dracunculiasis transmission and in areas reporting few cases of disease. Successful completion of the global campaign will require attention to the quality of surveillance, supervision of national eradication program staff, and implementation of interventions in each of the remaining disease-endemic countries, especially Ghana and Sudan.
The majority of persons who become regular smokers begin smoking during adolescence, making this period critical for preventing tobacco use (1) . Evidence suggests that antitobacco mass media campaigns that include paid television advertising reduce youth smoking (1) (2) (3) . With development of anti-tobacco programs in all 50 states during the 1990s, spurred by funding from the 1998 Master Settlement Agreement with major cigarette manufacturers, CDC, and other sources (4) , an increasing number of states instituted antitobacco media campaigns. This report summarizes trends in median state estimates for the average number of state-funded anti-tobacco television advertisements to which adolescents aged 12-17 years were exposed per month in 37 states* and (4) . Reduced exposure to state-funded anti-tobacco advertising might be contributing to the recent lack of substantial change in youth smoking prevalence from 2002 to 2004, which had been declining substantially since 1997 (5) . The majority of states need to implement additional measures to ensure that adolescents are adequately exposed to effective paid anti-tobacco advertisements as part of tobacco-prevention activities.
The monthly advertisement-exposure data used in this analysis were based on target ratings points (TRPs) for adolescents aged 12-17 years obtained from Nielsen Media Research (6) . TRPs are typically used as a mass-media exposure measure for a specific population during a defined period within a geographic media market, with 100 TRPs equaling an average of one exposure. Thus, if a television advertisement received 200 Figure) . State advertisement exposure estimates in 2003 ranged from no exposure in Louisiana, Maryland, and South Carolina to more than two exposures per month in Indiana, Minnesota, Ohio, Utah, Virginia, and Washington (Table) .
Research has demonstrated the effectiveness of several longrunning programs in reducing youth smoking that used extensive state-funded media advertising and began before 1999 (1, 2 (4, 8) . In Minnesota, program reductions were associated with reduced awareness of the state anti-tobacco campaign and a substantial increase in youth smoking susceptibility (8) . Downward trends in adolescent exposure to state-funded anti-tobacco ads in Arizona, California, Florida, and Massachusetts were particularly noteworthy, given their long-term use of state-funded anti-tobacco advertising.
Comprehensive state tobacco-prevention and -control programs have a key role in preventing tobacco use (1-3). Components of effective state programs include paid anti-tobacco television advertisements as part of countermarketing activities, community-based programs, school programs, cessationassistance efforts, and enforcement activities (7) . An additional challenge to effective tobacco countermarketing is that adolescents were exposed to more "anti-tobacco" advertisements sponsored by the tobacco industry than to state-funded antitobacco advertisements (9) . Research has indicated that tobacco industry-sponsored ads are not effective in preventing youth from smoking (10) .
State-funded anti-tobacco advertisements, however, cannot be effective on a populationwide basis if they do not achieve adequate exposure among target audiences. At a minimum, states should make every effort to ensure that adolescents are exposed to, on average, at least one state-funded anti-tobacco television advertisement per month, given that even this low level of exposure has been shown to be associated with higher anti-tobacco sentiment and reduced smoking prevalence (9) . Retaining sufficient levels of exposure consistently is especially important now that funding for the nationally aired and effective anti-tobacco advertisements produced by the American Legacy Foundation has been reduced (4).
The findings in this report are subject to at least five limitations. First, because Nielsen Media Research ratings measure the availability of audiences for advertising exposure, they do not guarantee actual viewing or recall of advertisements by adolescents. Nevertheless, Nielsen ratings are the standard approach used by corporations and others to estimate population exposure to television programs and advertising. Furthermore, research has demonstrated a dose-response relationship between estimated exposure of adolescents to antitobacco advertisements and their ability to recall seeing such advertisements (9) . Second, this study did not examine the actual content of anti-tobacco advertisements. Third, the estimated exposure levels did not reflect adolescent exposure to nationally aired anti-tobacco advertisements. Fourth, these data are not nationally representative, given that no data were available from 13 states. Finally, DMAs, although they cover the majority of the population in the 37 states and DC, might not be fully representative of estimated adolescent exposure throughout each state.
Tobacco use remains the leading preventable cause of death in the United States (1). However, reductions in state-funded anti-tobacco television advertisements might be contributing to the recent absence of a substantial change in adolescent cigarette smoking prevalence from 2002 to 2004 (i.e., from 22.5% to 21.8% among high school students, and from 9.8% to 8.3% among middle school students; neither difference was statistically significant) (5) . If these reductions continue, the Healthy People 2010 goal of reducing youth smoking prevalence to 16% by 2010 might not be achieved, and the shortterm cost savings that states gain by reducing their support for televised anti-tobacco advertising campaigns might produce long-term increased costs from smoking-related health effects.
Prevalence of Epilepsy and HealthRelated Quality of Life and Disability Among Adults with Epilepsy -South Carolina, 2003 and 2004
Epilepsy is a common neurologic disorder and poses substantial burdens on physical and mental health. Epilepsy can interfere with social functioning by limiting employment, educational opportunities, and interpersonal relationships and can increase the risk for death (1) . The annual cost of cases of epilepsy in the United States, including direct medical costs and productivity losses, was estimated at $12.5 billion in 1995 (2) . Depending on case definitions and populations studied, epilepsy affects an estimated 0.4%-1.0% of the population (3,4) with a lifetime prevalence of 1.8%-2.6% in certain state populations (5, 6) . This report analyzes data from the 2003 and 2004 South Carolina Behavioral Risk Factor Surveillance System (BRFSS) surveys, which included questions on epilepsy, health-related quality of life (HRQOL), and disability. This report summarizes the results of that analysis, which determined that 2.2% of adults in South Carolina had ever been told they had epilepsy, 1.1% had active epilepsy, and both groups reported worse HRQOL and higher prevalence of disability than those who had never had epilepsy. Healthcare providers should screen epilepsy patients for cognitive, emotional, and physical health problems that might negatively affect HRQOL (6) (7) (8) . Patients with active epilepsy and recent seizures should be targeted with interventions that will decrease the risk for adverse physical (e.g., injury) and psychosocial (e.g., unemployment) outcomes that accompany continued seizures (8) .
BRFSS is a state-based, random-digit-dialed telephone survey of the noninstitutionalized, U.S. civilian population aged >18 years. Data were weighted by sex, race, and age to adjust for differences between the survey population and the South Carolina population. A total of 5,926 respondents participated in the 2003 survey and 7,114 in the 2004 survey, for response rates of 41.6% and 43.8%, respectively. Results were considered significantly different if 95% confidence intervals (CIs) did not overlap.
BRFSS includes standard questions on key health-related behaviors and demographic characteristics; states can choose to add optional questions. In 2003 and 2004, South Carolina added four questions regarding epilepsy. The first question was "Have you ever been told by a doctor that you have a seizure disorder or epilepsy?" The lifetime prevalence of selfreported epilepsy was based on responses to this question, which had a response rate of 90.3%. Participants who answered yes to this question were also asked (where appropriate), "Are you currently taking any medicine to control your seizure disorder or epilepsy?", "How many seizures have you had in the last 3 months?", and "During the past 30 days, to what extent has epilepsy or its treatment interfered with your normal activities like working, school, or socializing with family or friends?" Respondents were considered to have active epilepsy if they 1) reported ever having been told by a doctor that they had a seizure disorder or epilepsy and 2) either were currently taking medicine to control epilepsy or had had one or more episodes of seizure during the preceding 3 months. Active epilepsy was categorized further by whether the respondent had had one or more seizures during the preceding 3 months.
In addition, all respondents, with and without epilepsy, were asked the following BRFSS core questions on HRQOL and activity limitation: "Now thinking about your physical health, which includes physical illness and injury, for how many days during the past 30 days was your physical health not good?", "Now thinking about your mental health, which includes stress, depression, and problems with emotions, for how many days during the past 30 days was your mental health not good?", and "During the past 30 days, for about how many days did poor physical or mental health keep you from doing your usual activities, such as self-care, work, or recreation?" CDC methods for calculating HRQOL were used (9) . Finally, to determine whether respondents were disabled, they were asked the BRFSS core question, "Are you limited in any way in any activities because of physical, mental, or emotional problems?"
Results indicated that an estimated 2.2% (95% CI = 1.8%-2.5%) of South Carolina adults had ever had epilepsy and that 1.1% (CI = 0.9%-1.4%) had active epilepsy (Table) . Among those with active epilepsy, an estimated 50.5% (CI = 38.9%-62.1%) had had one or more seizures during the preceding 3 months.
Adults who had ever had epilepsy had more mentally, physically, and overall unhealthy days and more activity-limitation days than those without epilepsy. Nearly half (46.7%) of those who had ever had epilepsy and 63.5% of those with active epilepsy reported some form of disability, compared with 17.9% of those without epilepsy. HRQOL factors were worse for those taking medicine to control their epilepsy than for those not taking medicine. Adults with active epilepsy had more than twice as many physically, mentally, and overall unhealthy days and activity-limitation days than those without epilepsy, and more overall unhealthy days and activitylimitation days than those with inactive epilepsy (Table) . Finally, a larger proportion of adults with active epilepsy reporting a seizure during the preceding 3 months reported disability than those without epilepsy, those with inactive epilepsy, or those with active epilepsy but no seizures during the preceding 3 months. Editorial Note: The 2.2% estimated lifetime prevalence of epilepsy in South Carolina is similar to recent estimated lifetime prevalence rates calculated from BRFSS data in Texas, Georgia, and Tennessee (5,6), and the 1.1% prevalence of active epilepsy is similar to that reported for Georgia in 2002 (6) . Results of the South Carolina BRFSS also confirm previous results indicating worse HRQOL (5) and indicate higher rates of disability among adults who have ever had epilepsy than among those without epilepsy. Results from the 2002 National Health Interview Survey indicated that adults who reported having seizures met criteria for serious mental illness more than four times as often as those who did not report having seizures (7) . Nonetheless, persons with epilepsy often remain undiagnosed and untreated for depression (1, 8, 10) .
Most of the overall cost of epilepsy results from treatment of persons with continuing seizures (2) ; approximately half of those in this study with active epilepsy reported seizures during the preceding 3 months. The goal of epilepsy treatment is to eliminate seizures and treatment side effects (1); continuing seizures might indicate inadequate treatment.
The findings in this report are subject to at least four limitations. First, all data are self-reported and not based on Additional information about national WNV activity is available from CDC at http://www.cdc.gov/ncidod/dvbid/ westnile/index.htm and at http://westnilemaps.usgs.gov.
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Notice to Readers
National Epilepsy Awareness Month --November 2005
November is National Epilepsy Awareness Month. Epilepsy affects approximately 2.7 million persons in the United States and is characterized by unprovoked seizures. Delayed recognition of seizures and inadequate treatment greatly increase the risk for subsequent seizures, brain damage, disability, decreased health-related quality of life, and death from injuries incurred during a seizure. Epilepsy most often affects young children and older adults, although persons can have epilepsy at any age. The effects of epilepsy on children can be especially burdensome as they transition into adulthood (e.g., driving and working). The number of cases among older adults is increasing as the U.S. population ages. Outside the medical community, epilepsy is a poorly understood condition, even among families and friends of affected persons.
To improve social acceptance and understanding of epilepsy and to increase support for persons living with it, the Epilepsy Foundation, in partnership with CDC, is expanding its campaign to focus on providing information about epilepsy to the Hispanic community through national and local partnerships, including Hispanic Radio Network, local affiliates 
